Differential Diagnosis and Molecular Stratification of Gastrointestinal Stromal Tumors on CT Images Using a Radiomics Approach.


Journal

Journal of digital imaging
ISSN: 1618-727X
Titre abrégé: J Digit Imaging
Pays: United States
ID NLM: 9100529

Informations de publication

Date de publication:
04 2022
Historique:
received: 24 03 2021
accepted: 14 01 2022
revised: 05 01 2022
pubmed: 29 1 2022
medline: 6 5 2022
entrez: 28 1 2022
Statut: ppublish

Résumé

Treatment planning of gastrointestinal stromal tumors (GISTs) includes distinguishing GISTs from other intra-abdominal tumors and GISTs' molecular analysis. The aim of this study was to evaluate radiomics for distinguishing GISTs from other intra-abdominal tumors, and in GISTs, predict the c-KIT, PDGFRA, BRAF mutational status, and mitotic index (MI). Patients diagnosed at the Erasmus MC between 2004 and 2017, with GIST or non-GIST intra-abdominal tumors and a contrast-enhanced venous-phase CT, were retrospectively included. Tumors were segmented, from which 564 image features were extracted. Prediction models were constructed using a combination of machine learning approaches. The evaluation was performed in a 100 × random-split cross-validation. Model performance was compared to that of three radiologists. One hundred twenty-five GISTs and 122 non-GISTs were included. The GIST vs. non-GIST radiomics model had a mean area under the curve (AUC) of 0.77. Three radiologists had an AUC of 0.69, 0.76, and 0.84, respectively. The radiomics model had an AUC of 0.52 for c-KIT, 0.56 for c-KIT exon 11, and 0.52 for the MI. The numbers of PDGFRA, BRAF, and other c-KIT mutations were too low for analysis. Our radiomics model was able to distinguish GISTs from non-GISTs with a performance similar to three radiologists, but less observer dependent. Therefore, it may aid in the early diagnosis of GIST, facilitating rapid referral to specialized treatment centers. As the model was not able to predict any genetic or molecular features, it cannot aid in treatment planning yet.

Identifiants

pubmed: 35088185
doi: 10.1007/s10278-022-00590-2
pii: 10.1007/s10278-022-00590-2
pmc: PMC8921463
doi:

Substances chimiques

Proto-Oncogene Proteins c-kit EC 2.7.10.1
Proto-Oncogene Proteins B-raf EC 2.7.11.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

127-136

Informations de copyright

© 2022. The Author(s).

Références

Eur J Radiol. 2018 Oct;107:90-97
pubmed: 30292279
Virchows Arch. 2018 Feb;472(2):221-229
pubmed: 29308530
Semin Diagn Pathol. 2006 May;23(2):70-83
pubmed: 17193820
Abdom Radiol (NY). 2018 Jul;43(7):1567-1574
pubmed: 29110055
Cancer Epidemiol. 2016 Feb;40:39-46
pubmed: 26618334
World J Gastroenterol. 2018 Jul 14;24(26):2806-2817
pubmed: 30018476
Hum Pathol. 2002 May;33(5):459-65
pubmed: 12094370
Eur J Radiol. 2013 Oct;82(10):e537-43
pubmed: 23910996
Biometrics. 1988 Sep;44(3):837-45
pubmed: 3203132
Abdom Radiol (NY). 2021 Jul;46(7):3075-3085
pubmed: 33713161
Acad Radiol. 2004 Feb;11(2):178-89
pubmed: 14974593
Curr Probl Diagn Radiol. 2017 Jan - Feb;46(1):17-25
pubmed: 26422114
Abdom Radiol (NY). 2018 Oct;43(10):2659-2664
pubmed: 29500645
IEEE J Biomed Health Inform. 2019 May;23(3):1181-1191
pubmed: 29993591
Hum Pathol. 2008 Oct;39(10):1411-9
pubmed: 18774375
J Chiropr Med. 2016 Jun;15(2):155-63
pubmed: 27330520
Clin Radiol. 2004 Jun;59(6):487-98
pubmed: 15145718
Neuroimage. 2017 Nov 1;161:149-170
pubmed: 28826946
Cancer Imaging. 2018 Dec 5;18(1):46
pubmed: 30518436
Eur Radiol. 2018 May;28(5):2058-2067
pubmed: 29335867
Cancer Res. 2017 Nov 1;77(21):e104-e107
pubmed: 29092951
J Gastrointest Cancer. 2014 Sep;45(3):262-7
pubmed: 24802226
Clin Cancer Res. 2012 Aug 15;18(16):4458-64
pubmed: 22718859
Eur Radiol. 2019 Mar;29(3):1074-1082
pubmed: 30116959
Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):1143-1158
pubmed: 30170872
Gastric Cancer. 2019 Jul;22(4):769-777
pubmed: 30535637
Arch Pathol Lab Med. 2006 Oct;130(10):1466-78
pubmed: 17090188
J Natl Compr Canc Netw. 2010 Apr;8 Suppl 2:S1-41; quiz S42-4
pubmed: 20457867
Clin Radiol. 2018 Mar;73(3):266-274
pubmed: 28969853
Eur Radiol. 2016 Sep;26(9):3086-93
pubmed: 26699371
Radiographics. 2013 Oct;33(6):1673-90
pubmed: 24108557
Br J Surg. 2019 Dec;106(13):1800-1809
pubmed: 31747074
Hum Pathol. 1998 Aug;29(8):791-800
pubmed: 9712419
J Nucl Med. 2018 Aug;59(8):1321-1328
pubmed: 29301932

Auteurs

Martijn P A Starmans (MPA)

Department of Radiology and Nuclear Medicine, Erasmus Medical Center, Rotterdam, The Netherlands. m.starmans@erasmusmc.nl.
Department of Medical Informatics, Erasmus Medical Center, Rotterdam, The Netherlands. m.starmans@erasmusmc.nl.

Milea J M Timbergen (MJM)

Department of Surgical Oncology, Erasmus MC Cancer Institute, Erasmus Medical Center, Rotterdam, The Netherlands.
Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus Medical Center, Rotterdam, The Netherlands.

Melissa Vos (M)

Department of Surgical Oncology, Erasmus MC Cancer Institute, Erasmus Medical Center, Rotterdam, The Netherlands.
Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus Medical Center, Rotterdam, The Netherlands.

Michel Renckens (M)

Department of Radiology and Nuclear Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.

Dirk J Grünhagen (DJ)

Department of Surgical Oncology, Erasmus MC Cancer Institute, Erasmus Medical Center, Rotterdam, The Netherlands.

Geert J L H van Leenders (GJLH)

Department of Pathology, Erasmus Medical Center, Rotterdam, The Netherlands.

Roy S Dwarkasing (RS)

Department of Radiology and Nuclear Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.

François E J A Willemssen (FEJA)

Department of Radiology and Nuclear Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.

Wiro J Niessen (WJ)

Department of Radiology and Nuclear Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.
Department of Medical Informatics, Erasmus Medical Center, Rotterdam, The Netherlands.
Faculty of Applied Sciences, Delft University of Technology, Delft, The Netherlands.

Cornelis Verhoef (C)

Department of Surgical Oncology, Erasmus MC Cancer Institute, Erasmus Medical Center, Rotterdam, The Netherlands.

Stefan Sleijfer (S)

Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus Medical Center, Rotterdam, The Netherlands.

Jacob J Visser (JJ)

Department of Radiology and Nuclear Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.

Stefan Klein (S)

Department of Radiology and Nuclear Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.
Department of Medical Informatics, Erasmus Medical Center, Rotterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH